Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States, in Belgium, in Bulgaria, .... It focuses on schizophrenia.
In United StatesThis study is completed in the United States. It is testing geodon for depression.
In United StatesThis study is completed in the United States, in Australia, in France, .... It is testing intramuscular Olanzapine Depot for schizophrenia.
In United StatesThis study was withdrawn in the United States. It is testing latuda for Bipolarity.
In United StatesThis study is completed in the United States. It is testing N-Acetylcysteine for Bipolarity.
In United StatesThis study is completed in the United States. It is testing SPN-812 Administered With Psychostimulants for ADHD.
In United StatesThis study was terminated in the United States. It is testing efficacy of Intranasal Oxytocin for schizophrenia.
In United StatesThis study is completed in the United States. It is testing long Term Tolerability and Safety of Atomoxetine for ADHD.
In United States
This study is completed in the United States. It is testing Usability of the Medical Information Device #1 System for schizophrenia.
In United StatesThis study is completed in the United States and in Canada. It focuses on Schizophrenia.
In United StatesThis study is active but not recruiting in the United States. It focuses on ADHD.
In United StatesThis study is completed in the United States, in France, in Canada, .... It is testing intramuscular Formulation of Aripiprazole for Bipolarity.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.